Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Single Helix Genomics logo — Personalized mRNA synthesis and therapeutics on-demand

Single Helix Genomics

Personalized mRNA synthesis and therapeutics on-demand

Founded 2020 United States Pleasanton, United States 1 employees Seed Biotechnology, Health and Wellness

General Information

Company Name Single Helix Genomics
Founded Year 2020
Location United States Pleasanton, United States
Employees 1
Industries Biotechnology, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Single Helix Genomics. To contact Single Helix Genomics, visit 1helixgenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Single Helix Genomics compare?

A PDF of Single Helix Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Single Helix Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Single Helix Genomics

Single Helix Genomics, a **biotechnology** startup founded in **2020** and headquartered in the **United States**, is pioneering personalized mRNA synthesis and therapeutics on-demand. The company's slogan, "Personalized mRNA synthesis and therapeutics on-demand," reflects its innovative approach to generating consistent, small-scale cGMP manufacturing of therapeutics-grade mRNA on a timescale of hours. This is made possible through an automated and portable therapeutics-on-demand (TOD) device developed by Single Helix Genomics. The company recently received a **Seed Round** investment on **02 November 2020** from **MBC Biolabs**, marking a significant milestone in its journey. This investment not only validates the potential of Single Helix Genomics' technology and business model but also provides the necessary resources to further develop and commercialize its offerings. With the support of investors like **MBC Biolabs**, Single Helix Genomics is well-positioned to make substantial strides in the field of personalized mRNA synthesis and therapeutics on-demand.

Business keywords: mRNA synthesis, therapeutics-on-demand, cGMP manufacturing, RNA therapeutics, vaccine development, portable device, microfluidic biochip, distributed manufacturing, pharmaceutical, custom RNA, pre-designed RNA, automated manufacturing, engineering, scientific innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
MBC Biolabs
MBC Biolabs
02 Nov 2020

Single Helix Genomics Alternatives & Competitors

View All Alternatives
Single Helix Genomics vs
Pantherna Therapeutics GmbH
Pantherna Therapeutics GmbH Germany

Developing novel mRNA-based therapeutics

Seed
11 employees
Biotechnology, Health Care
Single Helix Genomics vs
Ori Biotech
Ori Biotech United Kingdom

We're on a mission to enable widespread patient access to a new generation of lifesaving Cell and Ge...

Series B
68 employees
Automation, Biotechnology
Single Helix Genomics vs
Arcturus Therapeutics
Arcturus Therapeutics United States

A messenger RNA medicines company focused on the development of liver and respiratory rare disease t...

Grant
155 employees
Biotechnology, Health Care
View all alternatives

FAQ About Single Helix Genomics

Personalized mRNA synthesis and therapeutics on-demand
Single Helix Genomics was founded in 2020.
Single Helix Genomics is headquartered in Pleasanton, United States.
Single Helix Genomics operates in Biotechnology and Health and Wellness. Its work centres on mRNA synthesis, therapeutics-on-demand, cGMP manufacturing and RNA therapeutics.
Single Helix Genomics has approximately 1 employees.
Single Helix Genomics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Single Helix Genomics include Pantherna Therapeutics GmbH, Ori Biotech, Arcturus Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Single Helix Genomics and Pantherna Therapeutics GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Single Helix Genomics, https://bouncewatch.com/company/single-helix-genomics, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes